Investigación / Grupos de investigación

Grupo  702

Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas

Publicaciones (618)

  • Graupera, I; Thiele, M; Castera, L; Pera, G; Piano, S; Sòria, A; Fabrellas, N; Toran, P; Chacon, C; Bech, KT; Schnefeld, HL; Tonon, M; Incicco, S; Moussy, J; Lévy, V; Madir, A; Kukic, S; Havaj, DJ; Adamcova-Selcanova, S; Pustjens, J; van Kleef, LA; Jiménez-Masip, A; Pagès, L; Zoncapè, M; Weber, SN; Galle, PR; Harris, R; Ibanez-Samaniego, L; Morillas, RM; Diaz, A; Detlefsen, S; Serra-Burriel, M; Arslanow, A; Andersen, P; Pich, J; Bonfill, E; Korenjak, M; Fournier-Poizat, C; Llorca, A; Gourmelon, MC; de Koning, HJ; Pérez-Guasch, M; Ma, AT; Juanola, A; Pose, E; Arteaga, I; Villesen, I; Hansen, JK; Calvino, V; Gagliardi, R; Boutouria, B; Pastrovic, F; Kujundzic, PD; Zilincanova, D; Sulejova, KK; Rojo, D; de Knegt, RJ; Melo, MD; Torrejon, A; Hernández-Ibáñez, R; Hoyo, J; Munoz, L; López-Martos, R; Griffin, SJ; Manns, M; Karlsen, TH; Newsome, PN; Kamath, PS; Bañares, R; Guha, IN; Schattenberg, JM; Lammert, F; Tsochatzis, E; Brouwer, WP; Pericas, JM; Skladany, L; Grgurevic, I; Roulot, D; Angeli, P; Krag, A; Caballeria, L; Ginès, P.

    Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study

    LANCET. 2026; 407(10537): 1448-1458 Nº de citas: 13

  • Novoa, E; Parracho, T; Inderhees, J; Rodriguez, A; Riobello, C; Iglesias-Moure, J; Fernández-Iglesias, A; Martinez-Martinez, S; Senra, A; Seoane, S; Fondevila, M; Iglesias, C; Cabaleiro, A; Lima, ND; Dorta, V; López-Picallo, B; Ramos-Lage, L; Woodhoo, A; Fidalgo, M; Martinez-Chantar, ML; Cubero, FJ; López, M; Dieguez, C; Guallar, D; Prevot, V; Schwabe, RF; Frühbeck, G; Crespo, J; Varela-Rey, M; Gonzalez-Rellan, MJ; Gracia-Sancho, J; Iruzubieta, P; Schwaninger, M; Nogueiras, R.

    Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis

    Cell Metabolism. 2026; 38(4): 729-745 Nº de citas: 1 [doi:10.1016/j.cmet.2026.01.016]

  • Martínez-Lozano, H; Martínez-Ollero, J; Iniesta, C; Garrido-Bermejo, JC; Miranda-Bautista, J; Bighelli, F; Marín-Jiménez, I; Puerto, M; Bretón, I; Ramón, E; Menchén, L.

    Mesenteric Adipose Tissue Volume Predicts Response to Antitumor Necrosis Factor Therapy in Biological-Naïve Patients With Crohn's Disease

    Clinical and Translational Gastroenterology. 2026; 17(4): [doi:10.14309/ctg.0000000000000993]

  • Velamazán, R; Oyón, D; Lerma-Irureta, J; López-Guillén, P; Martínez-Domínguez, SJ; Arnau, A; Baroja, DA; Ruiz-Belmonte, LM; Tejedor-Tejada, J; Zapater, R; Martín-Vicente, N; Fernández-Esparcia, PJ; Gomara, ABJ; Lozano, VS; García, JJM; Martín-Falquina, IC; Pascual, LA; Monclus, NT; Velasco, NZ; Rojo, E; Cañamares-Orbís, P; Grau, LP; Lorenzo, MV; Arostegi, AI; Flores, V; Gomez, AD; de Paredes, AGG; Lapeña-Muñoz, B; García-Rayado, G; Bocos, JM; Borrego, V; Sostres, C; Lanas, A; Ramia, JM; de-Madaria, E.

    Waiting for cholecystectomy: determinants of prioritization for delayed cholecystectomy in a universal public healthcare system-post hoc analysis of RELAPSTONE cohort (WAIT-CHOL study)

    BJS Open. 2026; 10(2): [doi:10.1093/bjsopen/zrag021]

  • Sarmiento, E; Montanchez, J; Ezzahouri, I; Cifrian, J; Ortiz-Bautista, C; Laporta, R; Bravo, C; Salcedo, M; Rodriguez-Ferrero, ML; Gonzalez-Costello, J; Segovia, J; De Pablos, A; Mora, V; Ussetti, P; Lopez, S; Sabe, N; Gomez-Bueno, M; Sousa, I; Navas, P; Diez-Villanueva, P; Aguilar, M; Fernandez-Yunquera, A; Anaya, F; Muñoz, P; Valerio, M; Mur, A; Alarcon, A; Limay, K; Lopez-Hoyos, M; Lopez, F; Vionnet, A; Serrano, M; Carbone, J.

    Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial

    Transplantation Direct. 2026; 12(4): [doi:10.1097/TXD.0000000000001928]

  • López-García, A; Ferrer, CS; Maroto-Martín, C; Fernandez-Prada, SJ; Marquina, V; Glez, GER; Mesonero, F; Lucendo, AJ; Flórez-Díez, P; Casanova, MJ; García-Morales, N; Miranda-Bautista, J; Vicuña, M; Font, G; Benítez, JM; Bernal, L; Miquel, O; Mínguez, A; Tejedor-Tejada, J; Pérez-Galindo, P; Elosua, A; Lastiri, EA; Brunet-Mas, E; Llaó, J; Rodríguez-Lago, I; Ferreiro-Iglesias, R; López, L; González-Partida, I; Ortega, SP; Monsalve, S; González-Vivó, M; Márquez-Mosquera, L; Gonzalo, FM; Zabana, Y; Acosta, MBD.

    Esophageal, gastric and duodenal Crohn's disease in the biologic era: Results from a retrospective observational nationwide study of GETECCU

    DIGESTIVE AND LIVER DISEASE. 2026; 58(4): 464-472 [doi:10.1016/j.dld.2025.12.034]

  • Nyssen, OP; Jonaitis, L; Pérez-Aísa, A; Tepes, B; Mahmudov, U; Voynovan, I; Martínez-Domínguez, SJ; Bujanda, L; Lucendo, AJ; Vologzanina, L; Garre, A; Lerang, F; Abdulkhakov, SR; Pavoni, M; Denkovski, M; Mammadov, E; Leja, M; Tejedor-Tejada, J; Huguet, JM; Fadieienko, G; Tatiana, I; Pabón-Carrasco, M; Sarsenbaeva, AS; Zaytsev, O; Babayeva, G; Barrio, J; Areia, M; Perona, M; Núñez, O; Gravina, AG; Alekseenko, S; Rodríguez, BJG; Oglu, QFV; Ortiz-Polo, I; Loro, AM; Buzás, GM; Starostin, BD; Kupcinskas, J; Bordin, DS; Gasbarrini, A; Gridnyev, O; Marcos-Pinto, R; Jiménez-Moreno, M; Alonso, MS; Flores, V; Arteagoitia, I; Cano-Català, A; Parra, P; Moreira, L; Gisbert, JP.

    Real-World Effectiveness and Safety of Saccharomyces boulardii CNCM I-745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp-EuReg)

    HELICOBACTER. 2026; 31(2): Nº de citas: 2 [doi:10.1111/hel.70119]

  • Thomadakis, C; Gountas, I; Gountas, K; Nuño, N; Brime, B; Sendino, R; Albillos, A; Buti, M; Crespo, J; Berenguer, J; Alonso, S; de Santiago, AD; Hernando, V; Laguno, M; Lens, S; Diago, M; Montes, ML; García-Samaniego, J; Morano, L; Moreno, JL; Navarro, J; Romero-Gómez, M; Santos, L; Soriano, R; Duffell, E; Diaz, A; del Amo, J; Nikolopoulos, G.

    Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis

    JOURNAL OF VIRAL HEPATITIS. 2026; 33(4): Nº de citas: 1 [doi:10.1111/jvh.70159]

  • Díaz-González Á; Molera C; Gómez-Domínguez E; Muñoz-Bartolo G; Ampuero J; Fernández-Rodríguez C; Quintero J; Molina E; Salcedo M; Olveira A; Morillas R; Díez MA; Casado M; García-Buey L; Rodríguez-Tajes S; Jorquera F; Berenguer M; Montero JL; Londoño MC.

    Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP.

    Gastroenterologia y Hepatologia. 2026; 49(4): 502629-502629 Nº de citas: 2 [doi:10.1016/j.gastrohep.2025.502629]

  • Arvaniti P; Rodríguez-Tajes S; Padilla M; Olivas I; Mauro E; El Maimouni C; Lytvyak E; Verhelst X; Engel B; Taubert R; Lorente-Pérez S; Conde I; Riveiro-Barciela M; Ruiz-Cobo JC; Álvarez-Navascués C; Salcedo M; Gómez J; Janik MK; Mateos B; Efe C; Granito A; Dajti E; Azzaroli F; Horta D; Vila C; Castello I; Pérez-Medrano I; Arencibia A; Gerussi A; Bruns T; Colaprieto F; Lleo A; Van den Ende N; Verbeek J; Díaz-González Á; Morillas RM; Torner-Simó M; Bernal V; Fernández EM; Gevers TJG; Terziroli Beretta-Piccoli B; Gómez E; Cuenca P; de Boer YS; Kerkar N; Assis DN; Liberal R; Drenth JPH; Tana MM; Sebode M; Schregel I; Schramm C; Lohse AW; Montano-Loza AJ; Zachou K; Villamil A; Dalekos GN; Londoño MC.

    Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.

    Clinical Gastroenterology and Hepatology. 2026; 24(4): 1055-1067 Nº de citas: 7 [doi:10.1016/j.cgh.2025.02.010]

  • Olveira A; Crespo J; Ibañez-Samaniego L; Gallego-Durán R; Calleja JL; Aller R; Soria A; Gómez-Camarero J; Martín-Mateos R; Benlloch S; Pericàs JM; Morillas RM; Bernal-Monterde V; Diago M; Turnes J; Poca M; Lo Iacono O; Maya-Miles D; Escudero D; Andrade RJ; Rosales JM; Jorquera F; Fernández-Rodríguez C; Hernández-Guerra M; Romero-Gómez M; Ampuero J.

    Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic dysfunction-associated Steatotic Liver Disease in Clinical Practice.

    Clinical Gastroenterology and Hepatology. 2026; 24(4): 1044-1054 Nº de citas: 4 [doi:10.1016/j.cgh.2025.08.023]

  • Albéniz, E; Montori, S; Enguita-Germán, M; Marín-Gabriel, JC; de Tejada, AH; Wallenhorst, T; Rivory, J; Legros, R; Degand, T; Chevaux, JB; Ramos-Zabala, F; Le Baleur, Y; Rostain, F; Berger, A; Rosón, PJ; Terán, A; Barret, M; Leclercq, P; Chabrun, E; Schaeffer, M; Brieau, B; Boukechiche, S; Hijos-Mallada, G; Pioche, M; Jacques, J; Lupu, A; García, JS; Lepetit, H; Uchima, H; Rojo, FJG; García, JD; Albouys, J; Bonniaud, P; Chaussade, S; Rodríguez-Sánchez, J; Geay, J; Tenorio, AA; Belle, A; Dahan, M; Romero, DMG; de Santiago, ER; Parejo-Carbonell, S; Nogales, O; Plomteux, O; Zeevaert, JB; Fernández-Esparrach, G; Sánchez-Yagüe, A; Goikoetxea, U; Grainville, T; Estremera-Arevalo, F; Alonso, MG.

    External validation and optimization of the Limoges score to improve the delayed bleeding risk prediction after colorectal endoscopic submucosal dissection: the Delayed Bleeding ESD (DEBE) score

    ENDOSCOPY. 2026; 58(07): 741-752 [doi:10.1055/a-2814-4950]

  • García, JLR; Ferrer, CS; Molina, IGD; Rivas, C; Fernández-Clotet, A; Martínez, EC; Cuevas, CM; Balderramo, DC; Arias, L; Lozano, HM; Lorenzo, MV; Calafat, M; Rodríguez, DM; Ortega, JXS; Gisbert, JP; Brunet-Mas, E; González-Partida, I; Bataller, EC; Trastoy, PV; Pauta, KA; Escribano, LI; Marquès-Camí, M; Villafranca, CM; García, RMD; González, AE; Bastón-Rey, I; Martínez-Cadilla, J; Mariño, LP; Belén-Galipienso, O; García, PV; Latre, M; Rumbeu, PS; Mauri, AA; López-Martín, MC; Ponferrada-Díaz, A; López, MRA; Rodríguez-Sánchez, S; García, PMW; Ruiz-Ramírez, MA; Lozano, OM; Segura, PS; Bayonas, LM; Huguet, JM; Torres, G; Abreu, IA; Martín-Arranz, MD; Ciria, MM; Zabana, Y.

    Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(12): 1605-1616 Nº de citas: 4 [doi:10.1111/apt.70608]

  • Sanduzzi-Zamparelli, M; Matilla, A; Lledo, JL; Muñoz-Martínez, S; Varela, M; Iñarrairaegui, M; Perelló, C; Mínguez, B; Llarch, N; Márquez, L; Guerrero, A; Iserte, G; Castaño-García, A; Carrión, L; Fortuny, M; Rimola, J; García-Criado, A; Domenech, G; Torres, F; Rios-Guillermo, J; Boix, L; Samper, E; Kateb, A; Bruix, J; Reig, M.

    Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)

    ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(7): 955-966 Nº de citas: 3 [doi:10.1111/apt.70578]

  • de Santiago, ER; Sánchez-Vegazo, CT; Albéniz, E; Arévalo, FE; Gamboa, AA; Castel, I; Anta, JA; Marín-Gabriel, JC; Redondo, PD; Rodríguez, HN; De Tejada, AH; Martínez, IE; Pons, FR; Naves, JE; Uchima, H; Marín, I; Alcorta, JMD; Corte, DP; Pallarés, PD; Enciso, IP; Suarez, CG; Lorenzo-Zúñiga, V; Nogales, O; Muriel, A; Albillos, A; García, BP; Carbonell, SP; Sánchez, AM; Ganuza, M; Reina, AIR; Sanz, MD; De Frutos, D; Garcia, JS; Matallana, V; Relea, L; Priego, LB; Muñiz, MP; Bellver, VO; Lledó, JG; Hernández, JA; Segura, AM; Zamora, J; Neves, JAC; Sequeiros, EV.

    Multicenter, double-blind, sham endoscopy-controlled, randomized trial evaluating the efficacy of antireflux mucosal ablation for the treatment of gastroesophageal reflux disease

    ENDOSCOPY. 2026; 58(06): 595-607 Nº de citas: 5 [doi:10.1055/a-2780-0706]

  • Martín-Escolano, R; Fernández-Rodríguez, A; Tarancon-Diez, L; Berenguer, J; Codina, H; Amigot-Sánchez, R; González-García, J; Hontañón, V; Pérez-Latorre, L; Ibañez-Samaniego, L; Llop-Herrera, E; Olveira, A; Díaz, L; Martínez, I; Jiménez-Sousa, MA; Resino, S.

    HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis

    Frontiers in Immunology. 2026; 17: [doi:10.3389/fimmu.2026.1683092]

  • Astudillo-Guerrero, C; Garrido, A; Masferrer, D; Sepúlveda, C; Olavarría, L; Del Campo, R; Bravo-Sagua, R; Cubero, FJ; Salech, F; Thumala-Dockendorff, D; Urrutia, PJ; Quera, R; Bunout, D; Espinoza, R; Jorquera, G.

    Randomized, double-blind, placebo-controlled trial of fecal microbiota transplantation from young physically active donors to promote resilient aging: clinical trial protocol (ARMOR study)

    BMC Geriatrics. 2026; 26(1): [doi:10.1186/s12877-025-06920-7]

  • López-Calleja AM; López-Cauce B; Iborra Colomino M; Villarrubia-Martín B; Menchén L; Lobo-Rodríguez C.

    Fatigue in patients with inflammatory bowel disease: A descriptive cross-sectional study.

    Gastroenterologia y Hepatologia. 2026; 49(2): 502557-502557 [doi:10.1016/j.gastrohep.2025.502557]